A breakthrough therapy: polatuzumab vedotin plus BR for R/R DLBCL

"Dr Laurie Sehn, of the BC Cancer Agency, Vancouver, BC, Canada presents: 'Answering the unmet need in one of the most common types of lymphoma: Its as simple as A-D-C'. Dr Sehn discusses the us... Author: VJHemOnc Added: 08/15/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts